Mangalam Drugs & Organics Limited reported earnings results for the fourth quarter ended March 31, 2023. For the fourth quarter, the company reported sales was INR 902.72 million compared to INR 1,208.47 million a year ago. Revenue was INR 911.07 million compared to INR 1,209.56 million a year ago.

Net loss was INR 43.86 million compared to net income of INR 66.92 million a year ago. Basic loss per share from continuing operations was INR 2.77 compared to basic earnings per share from continuing operations of INR 4.23 a year ago. Diluted loss per share from continuing operations was INR 2.77 compared to diluted earnings per share from continuing operations of INR 4.23 a year ago.